Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients

Clinical trial NCT02119156 · COMPLETED

Trial details

NCT number: NCT02119156
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2014-05-13
Primary completion: 2018-12-14
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.